Early Thrombus in a HeartMate II Left Ventricular Assist Device: a Potential Cause of Hemolysis and Diagnostic Dilemma

Overview

Journal J Thorac Cardiovasc Surg

Specialties Cardiology & Vascular Diseases
General Surgery
Pulmonary Medicine

Date 2009 Dec 1

PMID 19945118

Citations 8

Authors

Castigliano M Bhamidipati

Gorav Ailawadi

James Bergin

John A Kern

Affiliations

Soon will be listed here.

Citing Articles

Special Considerations for Advanced Heart Failure Surgeries: Durable Left Ventricular Devices and Heart Transplantation.

Akbar A, Zhou A, Wang A, Feng A, Rizaldi A, Ruck J J Cardiovasc Dev Dis. 2024; 11(4).

PMID: 38667737 PMC: 11050210. DOI: 10.3390/jcdd11040119.

Influence of shear rate and surface chemistry on thrombus formation in micro-crevice.

Zhussupbekov M, Wu W, Jamiolkowski M, Massoudi M, Antaki J J Biomech. 2021; 121:110397.

PMID: 33845357 PMC: 8594740. DOI: 10.1016/j.jbiomech.2021.110397.

Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps.

Zhang J, Chen Z, Griffith B, Wu Z Int J Artif Organs. 2020; 43(10):653-662.

PMID: 32043405 PMC: 11549969. DOI: 10.1177/0391398820903734.

Pre-implant left ventricular apex position predicts risk of HeartMate II pump thrombosis.

Yarboro L, Mehaffey J, Hawkins R, Kron I, Ailawadi G, Kern J J Card Surg. 2017; 32(12):837-842.

PMID: 29226531 PMC: 5744885. DOI: 10.1111/jocs.13382.

New methodologies to accurately assess circulating active transforming growth factor-β1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices.

Mancini D, Monteagudo J, Suarez-Farinas M, Bander J, Varshney R, Gonzalez J Transl Res. 2017; 192:15-29.

PMID: 29175264 PMC: 5811316. DOI: 10.1016/j.trsl.2017.10.006.

References

Amir O, Bracey A, Smart F, Delgado 3rd R, Shah N, Kar B . A successful anticoagulation protocol for the first HeartMate II implantation in the United States. Tex Heart Inst J. 2006; 32(3):399-401. PMC: 1336719. View

John R, Kamdar F, Liao K, Colvin-Adams M, Miller L, Joyce L . Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg. 2008; 136(5):1318-23. DOI: 10.1016/j.jtcvs.2007.12.077. View

George I, Colley P, Russo M, Martens T, Burke E, Oz M . Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg. 2008; 135(6):1372-9. DOI: 10.1016/j.jtcvs.2007.11.049. View

Meyer A, Kuehn C, Weidemann J, Malehsa D, Bara C, Fischer S . Thrombus formation in a HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg. 2008; 135(1):203-4. DOI: 10.1016/j.jtcvs.2007.08.048. View

Klovaite J, Gustafsson F, Mortensen S, Sander K, Nielsen L . Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol. 2009; 53(23):2162-7. DOI: 10.1016/j.jacc.2009.02.048. View